NR4A1 and breast neoplasm: Since the breast, and majority of tumors derived from it are intricately controlled by hormone receptor signaling, we hypothesized that expression of a number of potential immunotherapeutic target proteins on breast tumors can be increased by modulation of hormone receptors controlling their transcription.